Neuropathic Pain Medication and Antidepressant Use after Disability Pension in Patients with Spinal Cord Stimulation for Persistent Spinal Pain Syndrome
Table 1
Demographics of 27 persistent spinal pain syndrome patients with spinal cord stimulation and disability pension collected in the Kuopio University Hospital in the period of 1996-2014.
SCS in use at the end of follow-up n = 27
Gender
Female
13 (48%)
Age on pension date (mean ± SD)
48 ± 6.5
Location of pain
Extremity
7 (26%)
Extremity and back
20 (74%)
Number of previous operations before implantation (median/range)
2/1–9
Level of operation (n = 25)
L4-5 and above
8 (32%)
L5-S1
7 (28%)
Multiple levels
10 (40%)
Reason for operation
Disc herniation
14 (52%)
Stenosis
4 (15%)
Disc herniation and stenosis
9 (33%)
Type of electrodea
Symmix/Resume 1 × 4/Vectris
21 (78%)
Specify 5-6-5/2 × 4
6 (22%)
Electrode location
T8-9
8 (30%)
T9-10
13 (48%)
T10–11
4 (15%)
T11–12
2 (7%)
Disability pension granted after implantation
11 (41%)
SCS = spinal cord stimulation; aall electrodes manufactured by Medtronic, Minneapolis, MN, USA.
